Delivery Order SPE2DB22D2206-SPE2DB24FHY42
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of a pharmaceutical product called MONOVISC 88 MG/4 ML SYRINGE 4ML. The $4,647.12 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition services to the U.S. Armed Forces and other government entities. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,360,860 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, valued at $7,220.08, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,647.12 for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, which has a completion date of June 28, 2024, was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $11,374.08 and an ultimate completion date of May 31, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,647.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,647.12 Firm Fixed Price delivery order contract has a July 2024 award date and a July 2024 ultimate completion date. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,699.85, is for the delivery of 4,566,110,541 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. This contract is not set aside for any small business designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous Indefinite Delivery Contracts...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of a pharmaceutical product called Monovisc 88 mg/4 ml syringe, 4 ml. The contract has a ceiling value of $10,225.88 and is a delivery order contract with a firm fixed price pricing type. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...